Scott Schoenhaus
Stock Analyst at Keybanc
(2.16)
# 2,622
Out of 4,827 analysts
102
Total ratings
40.91%
Success rate
-5.85%
Average return
Main Sectors:
Stocks Rated by Scott Schoenhaus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Maintains: Overweight | $30 → $32 | $23.72 | +34.91% | 5 | Apr 16, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $32 → $40 | $28.84 | +38.70% | 3 | Apr 16, 2025 | |
| PHR Phreesia | Maintains: Overweight | $30 → $28 | $24.40 | +14.75% | 7 | Apr 16, 2025 | |
| ODD Oddity Tech | Maintains: Overweight | $52 → $50 | $67.24 | -25.64% | 3 | Apr 16, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $110 → $100 | $91.72 | +9.03% | 5 | Apr 16, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $7 → $5 | $3.97 | +25.94% | 6 | Apr 16, 2025 | |
| DOCS Doximity | Maintains: Overweight | $83 → $70 | $58.36 | +19.95% | 3 | Apr 16, 2025 | |
| CERT Certara | Maintains: Overweight | $15 → $18 | $11.46 | +57.07% | 4 | Apr 16, 2025 | |
| ABCL AbCellera Biologics | Maintains: Overweight | $4 → $5 | $2.01 | +148.76% | 5 | Apr 16, 2025 | |
| ABSI Absci | Maintains: Overweight | $5 → $9 | $2.66 | +238.35% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $285 → $255 | $238.32 | +7.00% | 15 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $10 | $4.19 | +138.66% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $7 | $8.01 | -12.61% | 3 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $6 | $3.79 | +58.31% | 5 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $4.5 | $3.04 | +48.03% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $11 | $5.23 | +110.33% | 6 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $23.42 | - | 5 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $24.63 | - | 8 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $6.86 | - | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $180 → $250 | $153.30 | +63.08% | 2 | Apr 16, 2021 |
Schrödinger
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $32
Current: $23.72
Upside: +34.91%
Simulations Plus
Apr 16, 2025
Maintains: Overweight
Price Target: $32 → $40
Current: $28.84
Upside: +38.70%
Phreesia
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $28
Current: $24.40
Upside: +14.75%
Oddity Tech
Apr 16, 2025
Maintains: Overweight
Price Target: $52 → $50
Current: $67.24
Upside: -25.64%
HealthEquity
Apr 16, 2025
Maintains: Overweight
Price Target: $110 → $100
Current: $91.72
Upside: +9.03%
Health Catalyst
Apr 16, 2025
Maintains: Overweight
Price Target: $7 → $5
Current: $3.97
Upside: +25.94%
Doximity
Apr 16, 2025
Maintains: Overweight
Price Target: $83 → $70
Current: $58.36
Upside: +19.95%
Certara
Apr 16, 2025
Maintains: Overweight
Price Target: $15 → $18
Current: $11.46
Upside: +57.07%
AbCellera Biologics
Apr 16, 2025
Maintains: Overweight
Price Target: $4 → $5
Current: $2.01
Upside: +148.76%
Absci
Apr 16, 2025
Maintains: Overweight
Price Target: $5 → $9
Current: $2.66
Upside: +238.35%
Jan 8, 2025
Maintains: Overweight
Price Target: $285 → $255
Current: $238.32
Upside: +7.00%
Jan 8, 2025
Maintains: Overweight
Price Target: $12 → $10
Current: $4.19
Upside: +138.66%
Jan 8, 2025
Maintains: Overweight
Price Target: $10 → $7
Current: $8.01
Upside: -12.61%
Jan 8, 2025
Maintains: Overweight
Price Target: $7 → $6
Current: $3.79
Upside: +58.31%
Dec 9, 2024
Initiates: Overweight
Price Target: $4.5
Current: $3.04
Upside: +48.03%
Nov 13, 2024
Maintains: Overweight
Price Target: $10 → $11
Current: $5.23
Upside: +110.33%
May 10, 2024
Downgrades: Sector Weight
Price Target: n/a
Current: $23.42
Upside: -
Oct 11, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $24.63
Upside: -
Sep 16, 2022
Initiates: Sector Weight
Price Target: n/a
Current: $6.86
Upside: -
Apr 16, 2021
Upgrades: Overweight
Price Target: $180 → $250
Current: $153.30
Upside: +63.08%